LATANOPROST is a Ophthalmic Solution in the Human Prescription Drug category. It is labeled and distributed by Fdc Limited. The primary component is Latanoprost.
| Product ID | 55545-1010_987a5fd5-0afd-1d4e-e053-2a95a90a5d1d |
| NDC | 55545-1010 |
| Product Type | Human Prescription Drug |
| Proprietary Name | LATANOPROST |
| Generic Name | Latanoprost |
| Dosage Form | Solution |
| Route of Administration | OPHTHALMIC |
| Marketing Start Date | 2016-09-01 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA202442 |
| Labeler Name | FDC Limited |
| Substance Name | LATANOPROST |
| Active Ingredient Strength | 50 ug/mL |
| Pharm Classes | Prostaglandin Analog [EPC],Prostaglandins [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2016-09-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Ingredient | Strength |
|---|---|
| LATANOPROST | 50 ug/mL |
| SPL SET ID: | 891a5db6-ca9b-48f0-b3c6-7cd56e310c5a |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| PHarm Class EPC | |
| NUI Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0517-0830 | Latanoprost | Latanoprost |
| 13985-610 | Latanoprost | Latanoprost |
| 17478-625 | LATANOPROST | LATANOPROST |
| 21695-986 | Latanoprost | Latanoprost |
| 24208-463 | Latanoprost | latanoprost |
| 50090-1240 | LATANOPROST | LATANOPROST |
| 50090-1920 | Latanoprost | latanoprost |
| 55545-1010 | LATANOPROST | latanoprost |
| 59762-0333 | Latanoprost | Latanoprost |
| 61314-547 | Latanoprost | Latanoprost |
| 61919-112 | LATANOPROST | LATANOPROST |
| 64980-516 | LATANOPROST | latanoprost |
| 65862-872 | Latanoprost | Latanoprost |
| 68071-1683 | Latanoprost | Latanoprost |
| 68071-4650 | Latanoprost | Latanoprost |
| 68071-4612 | Latanoprost | Latanoprost |
| 71205-154 | Latanoprost | Latanoprost |
| 68071-4893 | LATANOPROST | LATANOPROST |
| 70069-421 | LATANOPROST | LATANOPROST |
| 0013-8303 | Xalatan | latanoprost |
| 47335-317 | XELPROS | latanoprost |